Message from the Chief

Faculty candidates and clinical fellowship applicants often ask me, “Why UCI?” The answer is simple. UCI is a special place where collegiality and collaboration are the norm, not the exception. This university is extraordinarily invested in its students, trainees and junior faculty. Mentorship opportunities abound, especially in cancer research. The School of Medicine prides itself on this culture of support and cooperativity.

As a Minority Thriving Campus, UCI is proud of its heritage as a Department of Education-designated Minority-Serving Institution, Hispanic-Serving Institution, and Asian American and Native American Pacific Islander-Serving Institution. Indeed, Wall Street Journal/Times Higher Education has named UCI number three in the nation for diversity.

The Division of Hematology and Oncology houses more than 50 faculty as full-time clinicians, clinical investigators, laboratory-based and population scientists, and advanced practitioners, along with our clinical fellowship training program. I am proud of the diversity within our division. Our faculty represents people from a broad diversity of racial/ethnic backgrounds and genders. More importantly, we demonstrate great diversity in how we practice, research, write and analyze data and literature – characteristics that are essential for high-quality academic and educational endeavors.

From a clinical perspective, we have expertise in all aspects of medical oncology, which are organized into disease-specific teams [link to division page with disease-specific teams]. At any given time, we are running approximately 200 clinical trials. All members of the Division of Hematology and Oncology function in support of our NCI-designated Chao Family Comprehensive Cancer Center.

I welcome you to browse our website to learn more about what the Division of Hematology and Oncology has to offer students, trainees and the cancer care community.

Sincerely,

Edward Nelson
Chief, Division of Hematology and Oncology